XTANDI® (enzalutamide soft capsules) Approved by China NMPA for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer ...Middle East

TOKYO, Nov. 6, 2020 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National Medical Products Administration (NMPA) has approved XTANDI® (enzalutamide soft capsules) for the treatment of adult men with...

Read More Details
Finally We wish PressBee provided you with enough information of ( XTANDI® (enzalutamide soft capsules) Approved by China NMPA for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer )

Also on site :

• Help! My Wife and Her Siblings Just Took Ancestry DNA Tests. All Hell’s Broken Loose.
• Wall Street’s advice after Nvidia hits historic $4 trillion market cap: BUY
• Cheez-Its confirms huge recipe change – new crackers are missing a key ingredient from the original version